Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures
Male
0301 basic medicine
MESH: Hippocampus
[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology
Blotting, Western
MESH: Neurons
Receptors, Nicotinic
MESH: Mice, Knockout
Hippocampus
MESH: Neurochemistry
MESH: Animals, Newborn
Antibodies
Mice
03 medical and health sciences
MESH: Mice, Inbred C57BL
Antibody Specificity
MESH: Bungarotoxins
MESH: Synaptic Transmission
MESH: Blotting, Western
Animals
MESH: Animals
Electrophoresis, Gel, Two-Dimensional
MESH: Antibody Specificity
MESH: Mice
Cerebral Cortex
Mice, Knockout
Neurons
MESH: Acetylcholine
MESH: Antibodies
MESH: Immunohistochemistry
Neurochemistry
MESH: Electrophoresis, Gel, Two-Dimensional
MESH: Protein Subunits
Bungarotoxins
Immunohistochemistry
MESH: Cerebral Cortex
MESH: Male
Acetylcholine
3. Good health
Mice, Inbred C57BL
Protein Subunits
Animals, Newborn
MESH: Receptors, Nicotinic
Female
MESH: Female
DOI:
10.1111/j.1471-4159.2007.04498.x
Publication Date:
2007-04-10T09:45:36Z
AUTHORS (20)
ABSTRACT
AbstractNicotinic acetylcholine receptors play important roles in numerous cognitive processes as well as in several debilitating central nervous system (CNS) disorders. In order to fully elucidate the diverse roles of nicotinic acetylcholine receptors in CNS function and dysfunction, a detailed knowledge of their cellular and subcellular localizations is essential. To date, methods to precisely localize nicotinic acetylcholine receptors in the CNS have predominantly relied on the use of anti‐receptor subunit antibodies. Although data obtained by immunohistology and immunoblotting are generally in accordance with ligand binding studies, some discrepancies remain, in particular with electrophysiological findings. In this context, nicotinic acetylcholine receptor subunit‐deficient mice should be ideal tools for testing the specificity of subunit‐directed antibodies. Here, we used standard protocols for immunohistochemistry and western blotting to examine the antibodies raised against the α3‐, α4‐, α7‐, β2‐, and β4‐nicotinic acetylcholine receptor subunits on brain tissues of the respective knock‐out mice. Unexpectedly, for each of the antibodies tested, immunoreactivity was the same in wild‐type and knock‐out mice. These data imply that, under commonly used conditions, these antibodies are not suited for immunolocalization. Thus, particular caution should be exerted with regards to the experimental approach used to visualize nicotinic acetylcholine receptors in the brain.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (57)
CITATIONS (172)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....